Home - RegMed XB | Regenerative Medicine Crossing Borders

RegMed XB

Regenerative Medicine Crossing Borders

RegMed XB

News

FIRST participates in 1.8 million seed investment for the discovery of two new drugs for heart failure

FIRST participates in 1.8 million seed investment for the discovery of two new drugs for heart failure

River BioMedics, a drug discovery company using advanced 3D human cardiac models, today announced the closure of a 1.8 million Euro seed funding round to progress its research and innovation programs for cardiovascular disease targets and compounds.

Realisation of national Pilot factory for regenerative medicine has started

Realisation of national Pilot factory for regenerative medicine has started

RegMed XB has received the first subsidy of 23 million euros from the Ministry of Economic Affairs and Climate Policy. This is the start of the realization of the national pilot factory for regenerative medicine after the Dutch cabinet decided on 9 April this year to fund the National Growth Fund proposal of RegMed XB.

RegMed XB partner LUMC receives 100 million euros for research for stem cell based therapies

RegMed XB partner LUMC receives 100 million euros for research for stem cell based therapies

Leiden University Medical Centre (LUMC), the DanStem Institute at the University of Copenhagen and the Murdoch Children's Research Institute in Melbourne will jointly receive 300 million euros from the Novo Nordisk Foundation.

Events

Annual Meeting
06-07-2022
Eindhoven

Discover RegMed XB

Copyright © 2021 RegMed XB. All rights reserved
Realisation & design by Joomlapartner